Rezolute
Academic / Other · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism Tumor Hyperinsulinism (Tumor HI) | Phase 3 | 2025-04-16 |
| Active Not Recruiting | RZ358 Treatment for Congenital Hyperinsulinism Congenital Hyperinsulinism | Phase 3 | 2024-01-11 |
| Completed | Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME) Diabetic Macular Edema | Phase 2 | 2023-02-06 |
| Completed | An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism Congenital Hyperinsulinism | Phase 2 | 2020-02-24 |
| Available | Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor-associated Hyperinsulinism (Tumor HI) | — | — |